Helene von Roeder, Merck KGaA CFO (Arne Dedert/picture-alliance/dpa/AP Images)
May 15, 2025 07:03 AM EDTUpdated 10:53 AM
China
Pharma
Manufacturing

Up­dat­ed: Mer­ck KGaA con­tin­ues US tar­iff sur­charge but at a 'de­creased' rate 

Anna Brown

News Reporter

Ayisha Sharma

News Reporter

De­spite paus­ing a tar­iff sur­charge for Chi­na-based clients, Mer­ck KGaA will car­ry on with adding an ex­tra charge for US cus­tomers to ac­count for Pres­i­dent …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­haven stock sinks on three-month de­lay for neu­ro drug's FDA ap­proval de­ci­sion

Ex­clu­sive: Drug com­pounder Em­pow­er was built on risky short­cuts, ex-em­ploy­ees and in­spec­tions al­lege

Hen­grui, one of Chi­na's lead­ing biotechs, an­tic­i­pates $1.2B in pro­posed Hong Kong list­ing

FDA gives Ab­b­Vie ac­cel­er­at­ed ap­proval for an­ti­body-drug con­ju­gate in lung can­cer

Ex­clu­sive: 17 health sys­tems are work­ing with Abun­dant Ven­ture Part­ners to de­vel­op tech

RFK Jr. de­fends HHS staff cuts, re­or­ga­ni­za­tion plans in House, Sen­ate hear­ings

A service from the Financial Times